title: Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
abstract: This is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease.
authors: Can
authors: C
authors: Boğa
authors: Zahit
authors: Z
authors: Bolaman
authors: Seçkin
authors: S
authors: Çağırgan
authors: İhsan
authors: İ
authors: Karadoğan
authors: Mehmet Ali
authors: MA
authors: Özcan
authors: Fahir
authors: F
authors: Özkalemkaş
authors: Rabin
authors: R
authors: Saba
authors: Mehmet
authors: M
authors: Sönmez
authors: Esin
authors: E
authors: Şenol
authors: Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey Phone: +90 532 424 26 40 E-mail: hamdiakan@gmail.com.
authors: Hamdi
authors: H
authors: Akan
authors: Murat
authors: M
authors: Akova
mesh_terms: D000935:Antifungal Agents / Q000097:blood / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control; D004203:Disinfection / Q000379:methods; D064147:Febrile Neutropenia / Q000139:chemically induced / Q000150:complications; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D000072742:Invasive Fungal Infections / Q000209:etiology / Q000517:prevention & control*; D009894:Opportunistic Infections / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D019172:Transplantation Conditioning / Q000009:adverse effects
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents